Pharmacology, Toxicology and Pharmaceutical Science
Gonorrhea
100%
Randomized Controlled Trial
91%
Metronidazole
63%
Ceftriaxone
60%
Pelvic Inflammatory Disease
59%
Gentamicin
58%
Vaginitis
55%
Infection
46%
HIV
46%
Lactic Acid
40%
Azithromycin
38%
Neisseria gonorrhoeae
37%
Antimicrobial Resistance
35%
Antibiotics
34%
Antibiotic Therapy
29%
Chlamydiae
20%
Syphilis
19%
Tenofovir
19%
Side Effect
17%
Mycoplasma genitalium
16%
Nucleic Acid
16%
Intramuscular Injection
15%
Urethritis
13%
Recurrent Disease
13%
Cefixime
12%
Medicine and Dentistry
Gonorrhea
79%
Pelvic Inflammatory Disease
70%
Human Immunodeficiency Virus
67%
Randomized Controlled Trial
57%
Infection
56%
Bacterial Vaginosis
54%
Metronidazole
54%
Systematic Review
49%
Health Service
34%
Antibiotic Resistance
31%
Lactic Acid
30%
Nucleic Acid Amplification
30%
Neisseria gonorrhoeae
29%
Gentamicin
27%
Arm
27%
Mycoplasma genitalium
25%
Antiretroviral Therapy
24%
Antibiotic Therapy
24%
Chlamydiae
23%
Ceftriaxone
23%
Odds Ratio
21%
Cohort Analysis
21%
Health Promotion
19%
Menopausal Symptom
19%
Prospective Cohort Study
19%
Nursing and Health Professions
Health Care
63%
Human Immunodeficiency Virus
61%
Systematic Review
59%
Sexual Violence
48%
Gonorrhea
45%
Health Center
40%
Odds Ratio
33%
Infection
22%
Antimicrobial Resistance
21%
Health Care Personnel
20%
Intramuscular Drug Administration
20%
Economic Evaluation
19%
Lactic Acid
19%
Metronidazole
19%
Vaginitis
19%
Confidence Interval
19%
Ceftriaxone
18%
Injection Pain
17%
High Risk Population
14%
CINAHL
12%
Quality of Life
11%
PsycINFO
10%
Injection Site
10%
Injection Site Pain
10%
Meta Analysis
9%
